Please try another search
SpectraScience, Inc. is focused on developing its WavSTAT Optical Biopsy System (WavSTAT). The WavSTAT employs a risk technology that optically illuminates tissue in real-time to distinguish between normal and pre-cancerous or cancerous tissue. The Company has developed a technology platform to determine if tissue is normal, pre-cancerous or cancerous, without the need for a physical biopsy. The WavSTAT4 Optical Biopsy System operates by using cool, safe ultraviolet (UV) laser light to optically illuminate and analyze tissue, enabling the physician to make a diagnosis during endoscopy when screening for cancer and, if warranted, to begin immediate treatment during the same procedure. The WavSTAT4 uses laser-induced auto-fluorescence to obtain spectral information from tissue at the suspected site. The system is classified as a non-significant risk device, which transmits low-level UV laser light energy through an optical fiber to the tissue through the working channel of an endoscope.
Name | Age | Since | Title |
---|---|---|---|
Sheldon L. Miller | 86 | 2010 | Director |
Rand P. Mulford | 78 | 2014 | Independent Director |
Mark D. McWilliams | 65 | 2004 | Chairman |
F. Duwaine Townsen | 89 | 2009 | Independent Director |
Stanley J. Pappelbaum | 84 | 2006 | Independent Director |
Thomas G. Thompson | 80 | 2007 | Chairman of the Advisory Board |
Michael P. Oliver | 74 | 2010 | CEO, President, COO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review